Nektar Therapeutics (NKTR) — Cash Flow Quality Index
Nektar Therapeutics (NKTR) has a Cash Flow Quality Index of -6.36x as of December 2024. Operating cash flow of $-46.19 Million is below net income of $7.26 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Nektar Therapeutics (NKTR) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nektar Therapeutics Cash Flow Quality Index (2018–2018)
Historical Cash Flow Quality Index for Nektar Therapeutics across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NKTR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Nektar Therapeutics (2018–2018)
Year-by-year earnings quality comparison for Nektar Therapeutics. For live market cap and the full company financial profile, see Nektar Therapeutics stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.05x | $718.21 Million | $681.31 Million | — |